Physician profile
Omar Samih Qaqish
NPI 1578067369
$44,852.68
in general payments reported to CMS, 2019-2025
31 companies · $5,938 in 2025
The $5,938 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $639 · 2022: $2,944 · 2023: $4,137 · 2024: $31K · 2025: $5,938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $21K · Gift: $9,360 · Food and Beverage: $8,966 · Grant: $1,063 · Education: $471 · Consulting Fee: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $21,108.89 |
| Gift | $9,360.00 |
| Food and Beverage | $8,966.01 |
| Grant | $1,063.30 |
| Education | $470.70 |
| Consulting Fee | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $27,598.04 | 2022-2025 | (9520) Igt Devices Undivided, (Bq9) Coronary Ivus, Coronary Other |
| Abbott Laboratories | $5,685.14 | 2022-2025 | Prostar, Gallant, Optis |
| Inari Medical, INC. | $2,854.87 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $1,837.16 | 2022-2024 | Lux-Dx Insertable Cardiac Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,468.66 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $877.57 | 2021-2023 | Farxiga |
| Abiomed | $555.41 | 2022-2024 | Impella |
| Merit Medical Systems INC | $509.65 | 2022 | |
| Medtronic, INC. | $459.90 | 2021-2024 | Turbohawk, Venaseal, Onyx Frontier |
| Actelion Pharmaceuticals US, INC. | $444.00 | 2021-2022 | |
| Cardiva Medical, INC. | $362.62 | 2024-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Shockwave Medical, INC | $282.83 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $264.77 | 2024 | Indigo System |
| Kestra Medical Technology Services, INC. | $231.67 | 2024-2025 | Assure Wcd |
| Stryker Corporation | $226.97 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $219.11 | 2023 | Amvuttra |
| Teleflex LLC | $182.24 | 2025 | Guideliner |
| Kiniksa Pharmaceuticals International, Plc | $145.82 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $129.09 | 2022-2024 | Xarelto |
| Angiodynamics, INC. | $121.47 | 2024 | Alphavac |
| Chiesi USA, INC. | $89.88 | 2024-2025 | Kengreal, Cleviprex |
| Cordis US Corp. | $62.23 | 2023-2025 | Mynx Control, Mynx Control Venous |
| Merck Sharp & Dohme LLC | $43.88 | 2022-2023 | Verquvo |
| Pfizer INC. | $36.87 | 2023-2024 | |
| Terumo Medical Corporation | $34.60 | 2023-2024 | Tr Band, Angio-Seal |
| Lexicon Pharmaceuticals, INC. | $30.36 | 2023 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.67 | 2025 | Jardiance |
| Siemens Medical Solutions USA, INC. | $20.97 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.53 | 2024 | |
| Cardiovascular Systems INC. | $15.54 | 2022 | |
| Scpharmaceuticals INC. | $15.16 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Qaqish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.